The Effect of Gender Bias in Surveys of Patients With Myeloproliferative Neoplasm
Gender balance in cancer surveys of patients with myeloproliferative neoplasms was found to have relatively little effect on survey outcomes.
All articles by Jessica Nye, PhD
Fecal Hemoglobin Concentration May Predict Advanced Neoplasia, Colorectal Cancer
Researchers developed and assessed logistic prediction models for the detection of advanced neoplasia and colorectal cancer.
Infection, Tumor Lysis Syndrome Incidence During Initial Days of HMA/Venetoclax Therapy for AML
A retrospective analysis sought to determine the real world outcomes for patients with AML treated with venetoclax and azacitidine or decitabine.
Breast Cancer Regimen Safety, Efficacy in Men Similar to All Patients, Study Finds
Safety and efficacy outcomes with ribociclib plus letrozole were similar in men and women with HR+ HER2− breast cancer.
Mitigation Strategies Reduce Adverse Events After Cilta-Cel
Researchers sought to identify predictors of movement and neurocognitive treatment-emergent adverse events in patients undergoing CAR T-cell therapy.
Longer Azacitidine Schedule Delayed Transformation to Leukemia in Patients With MDS
A 7-day azacitidine schedule delayed the time to leukemia transformation and improved survival in patients with higher-risk MDS.
Depression, Anxiety Rates High With Androgen Deprivation Therapy for Prostate Cancer
An analysis revealed a link between treatment with androgen deprivation therapy and new diagnoses of incident depression and anxiety in men with prostate cancer.
Antibiotic Treatment Not Associated With Risk for Early-Onset Colorectal Cancer
Researchers in Sweden sought to explore whether receiving treatment with antibiotics was associated with risk for early-onset colorectal cancer.
Low Serum Complement C4 Predicts Poorer Outcomes in Newly Diagnosed MM
Researchers sought to confirm an association between serum complement C4 levels and outcomes in patients with newly diagnosed multiple myeloma.
Perioperative Cemiplimab Shows Clinical Activity Among Patients With Early-Stage Hepatocellular Carcinoma
Investigators assessed the safety and efficacy of neoadjuvant cemiplimab for treatment of patients with early-stage, resectable hepatocellular carcinoma.
- Loading...
Loading...
Next post in Gastrointestinal Cancers
Loading... 
Loading...